{
  "schemaVersion": 1,
  "id": "research-289",
  "slug": "289-what-a-multisite-oxytocin-trial-found-about-heavy-drinking-days",
  "title": "What a Multisite Oxytocin Trial Found About Heavy Drinking Days",
  "catalogLabel": "Oxytocin",
  "productCollection": "https://heritagebiolabs.com/research-library/products/oxytocin",
  "productHandles": [
    "oxytocin-699"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/oxytocin-699"
  ],
  "readingFocus": "Study findings",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 271,
  "sourceYears": [
    2026
  ],
  "paragraphs": [
    "A peptide is a short amino-acid chain connected by peptide bonds. Some peptide hormones participate in signals related to stress or behavior. Oxytocin has been studied in people with alcohol use disorder because laboratory findings suggested that it might affect processes involved in drinking. A 2026 multisite randomized trial tested that idea with a prespecified measure of drinking behavior. Its main result did not establish a benefit. [1]",
    "Nassima Ait-Daoud Tiouririne and colleagues compared intranasal oxytocin with placebo in 100 people with alcohol use disorder. The trial lasted 12 weeks. Its primary outcome was the percentage of heavy drinking days during the maintenance phase. This is a different measure from what a participant reports about craving, anger, sleep or mood. Selecting one main outcome in advance helps readers judge the treatment hypothesis consistently. [1]",
    "The researchers did not find a statistically significant difference in the main drinking measure. They also reported no clear difference on several related outcomes, including craving. Some end-of-treatment measures of anger and aggression differed, and the authors described a small numerical drinking difference late in the trial. These are separate observations. An exploratory or secondary finding can suggest a question for future research, but it does not replace the prespecified outcome. [1]",
    "The paper reported mostly mild adverse events with comparable patterns in the two groups. That describes the participants and observation period studied. It does not establish safety in other settings or in combination with other medicines. The trial is useful precisely because it tested a biological idea against a meaningful human outcome. Its finding limits claims that oxytocin reduces heavy drinking in this population. [1]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "Ait-Daoud Tiouririne N et al. Intranasal Oxytocin for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled Multisite Trial Assessing Efficacy and Safety. Alcohol, Clinical and Experimental Research (2026-07).",
      "url": "https://pubmed.ncbi.nlm.nih.gov/42458234/"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/289-what-a-multisite-oxytocin-trial-found-about-heavy-drinking-days",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/289-what-a-multisite-oxytocin-trial-found-about-heavy-drinking-days.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/289-what-a-multisite-oxytocin-trial-found-about-heavy-drinking-days.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 058 - Oxytocin.docx",
    "sourceArticleNumber": 289,
    "contentSha256": "e11afcb0a7f658ec0983c7bfdb5ab73f464ad4c366da5ce407cbe5ad9f4987b6",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
